Alberto Ortega Guerra

Title: Alberto Ortega Guerra: Innovator in Biocatalysis

Introduction

Alberto Ortega Guerra is a prominent inventor based in Menlo Park, California. He has made significant contributions to the field of biocatalysis, holding two patents that showcase his innovative work. His inventions focus on the development of engineered enzymes that have applications in the pharmaceutical industry.

Latest Patents

One of Alberto's latest patents is titled "Biocatalysts and methods for hydroxylation of chemical compounds." This invention provides engineered proline hydroxylase polypeptides for the production of hydroxylated compounds. It includes polynucleotides encoding the engineered proline hydroxylases, host cells capable of expressing these enzymes, and methods for using them to prepare compounds useful in the production of active pharmaceutical agents.

Another significant patent is for "Engineered acetate kinase variant enzymes." This invention offers engineered acetate kinase (AcK) enzymes, polypeptides with AcK activity, and polynucleotides encoding these enzymes. It also includes vectors and host cells that comprise these polynucleotides and polypeptides. Methods for producing AcK enzymes are provided, along with compositions that include the AcK enzymes and methods for their use, particularly in the production of pharmaceutical compounds.

Career Highlights

Alberto Ortega Guerra is currently associated with Codexis, Inc., a company known for its focus on enzyme engineering and biocatalysis. His work at Codexis has allowed him to contribute to advancements in the production of pharmaceutical agents through innovative enzyme technologies.

Collaborations

Alberto collaborates with talented individuals such as Jonathan Vroom and Jovana Nazor, who are also part of the innovative team at Codexis. Their combined expertise fosters a creative environment that drives the development of cutting-edge biocatalytic solutions.

Conclusion

Alberto Ortega Guerra is a key figure in the field of biocatalysis, with patents that reflect his commitment to advancing pharmaceutical production through engineered enzymes. His work continues to impact the industry positively, showcasing the importance of innovation in science and technology.